Journal of Preventive Medicine and Public Health

  • 제57권6호
  • /
  • Pages.595-599
  • /
  • 2024
  • /
  • 1975-8375(pISSN)
  • /
  • 2233-4521(eISSN)
대한예방의학회 (The Korean Society for Preventive Medicine)
권호 표지
DOI QR코드

DOI QR Code

Pseudoephedrine-induced Fixed Drug Eruption in a Scuba Diver With Recurrent Palmoplantar Exfoliation

  • 투고 : 2024.06.24
  • 심사 : 2024.08.01
  • 발행 : 2024.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This report presents a case of pseudoephedrine-induced non-pigmented bullous fixed drug eruption (NBFDE) manifesting as recurrent palmoplantar exfoliation in a scuba diver. It emphasizes the importance of considering drug allergies in the differential diagnosis when divers present with peeling hands and soles. A 38-year-old female scuba diver experiencing recurrent palmoplantar exfoliation underwent a clinical evaluation, patch testing, an interferon-gamma enzyme-linked immunospot (ELISpot) assay, and graded drug challenges with pseudoephedrine and phenylephrine. Patch testing yielded negative results; however, the ELISpot assay indicated a strong immune response to pseudoephedrine. A graded challenge involving pseudoephedrine successfully reproduced the symptoms, confirming a diagnosis of pseudoephedrine-induced NBFDE. Subsequently, a challenge with phenylephrine elicited a milder reaction, suggesting it as a potential alternative medication for the patient. This case highlights NBFDE as a potential cause of skin peeling in scuba divers who are allergic to pseudoephedrine. It emphasizes the importance of considering drug allergies when diagnosing palmoplantar exfoliation in divers and underscores the need for a thorough evaluation of medication use in this group. Alternative medications and management strategies should be considered for divers with a pseudoephedrine allergy to prevent ear barotrauma while minimizing the risk of adverse skin reactions.

키워드

과제정보

This study was supported by the Center of Excellence for Skin and Allergy Research, Chulalongkorn University, Bangkok, Thailand.

참고문헌

  1. Thornton NJ, Garcia B, Hoyer P. Aquatic antagonists: marine rashes (seabather's eruption and diver's dermatitis). Cutis 2022; 109(5):255-260. https://doi.org/10.12788/cutis.0522
  2. Okamoto H, Nakajima T, Ito Y, Aketo T, Shimada K, Yamato S. Simultaneous determination of ingredients in a cold medicine by cyclodextrin-modified microemulsion electrokinetic chromatography. J Pharm Biomed Anal 2005;37(3):517-528. https://doi.org/10.1016/j.jpba.2004.11.011
  3. Kim KH, Jun M, Lee MK. Bioavailability of the common cold medicines in jellies for oral administration. Pharmaceutics 2020; 12(11):1073. https://doi.org/10.3390/pharmaceutics12111073
  4. Chongpison Y, Sriswasdi S, Buranapraditkun S, Thantiworasit P, Rerknimitr P, Mongkolpathumrat P, et al. IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivity. J Allergy Clin Immunol 2024;153(1): 193-202. https://doi.org/10.1016/j.jaci.2023.08.026
  5. Barranco R, Rodríguez A, de Barrio M, Trujillo MJ, de Frutos C, Matheu V, et al. Sympathomimetic drug allergy: cross-reactivity study by patch test. Am J Clin Dermatol 2004;5(5):351-355. 599 https://doi.org/10.2165/00128071-200405050-00008
  6. Pierobon E, Germi L, Sechi A, Trevisan G, Pezzolo E, Feliciani C, et al. Keratolysis exfoliativa-like eruption induced by ranolazine. Dermatol Reports 2022;14(1):9264. https://doi.org/10.4081/dr.2022.9264
  7. Nikolaou V, Syrigos K, Saif MW. Incidence and implications of chemotherapy related hand-foot syndrome. Expert Opin Drug Saf 2016;15(12):1625-1633. https://doi.org/10.1080/14740338.2016.1238067
  8. Otsuka H, Fukumoto T, Oka M, Nishigori C. Case report: severe non-pigmenting fixed drug eruption showing general symptoms caused by chondroitin sulfate sodium. Front Med (Lausanne) 2022;9:1041492. https://doi.org/10.3389/fmed.2022.1041492
  9. Vidal C, Prieto A, Pérez-Carral C, Armisén M. Nonpigmenting fixed drug eruption due to pseudoephedrine. Ann Allergy Asthma Immunol 1998;80(4):309-310. https://doi.org/10.1016/ S1081-1206(10)62974-2
  10. Shelley WB, Shelley ED. Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline. J Am Acad Dermatol 1987;17(3):403-407. https://doi.org/10.1016/s0190-9622(87)70220-5
  11. Anderson HJ, Lee JB. A review of fixed drug eruption with a special focus on generalized bullous fixed drug eruption. Medicina (Kaunas) 2021;57(9):925. https://doi.org/10.3390/medicina57090925
  12. Traineau H, Milpied B, Soria A, Assier H, Tetart F, Bernier C, et al. In situ patch test and repeated open application test for fixed drug eruption: a multicenter study. J Allergy Clin Immunol Pract 2024;12(2):460-468. https://doi.org/10.1016/j.jaip.2023.10.021